The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model
Introduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debat...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/4587907 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554750021730304 |
---|---|
author | Denisa Miklankova Irena Markova Martina Hüttl Barbora Stankova Hana Malinska |
author_facet | Denisa Miklankova Irena Markova Martina Hüttl Barbora Stankova Hana Malinska |
author_sort | Denisa Miklankova |
collection | DOAJ |
description | Introduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results. Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions. Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism. |
format | Article |
id | doaj-art-26e94ca82d9c4cec87d8e861d37f6ebe |
institution | Kabale University |
issn | 2314-6753 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Diabetes Research |
spelling | doaj-art-26e94ca82d9c4cec87d8e861d37f6ebe2025-02-03T05:50:36ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/4587907The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes ModelDenisa Miklankova0Irena Markova1Martina Hüttl2Barbora Stankova3Hana Malinska4Centre for Experimental MedicineCentre for Experimental MedicineCentre for Experimental MedicineFirst Faculty of MedicineCentre for Experimental MedicineIntroduction. Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results. Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions. Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.http://dx.doi.org/10.1155/2022/4587907 |
spellingShingle | Denisa Miklankova Irena Markova Martina Hüttl Barbora Stankova Hana Malinska The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model Journal of Diabetes Research |
title | The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model |
title_full | The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model |
title_fullStr | The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model |
title_full_unstemmed | The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model |
title_short | The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model |
title_sort | different insulin sensitising and anti inflammatory effects of palmitoleic acid and oleic acid in a prediabetes model |
url | http://dx.doi.org/10.1155/2022/4587907 |
work_keys_str_mv | AT denisamiklankova thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT irenamarkova thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT martinahuttl thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT barborastankova thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT hanamalinska thedifferentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT denisamiklankova differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT irenamarkova differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT martinahuttl differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT barborastankova differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel AT hanamalinska differentinsulinsensitisingandantiinflammatoryeffectsofpalmitoleicacidandoleicacidinaprediabetesmodel |